This article is more than 5 years old. Information may no longer be current.
Kristin Chenoweth kicks off rosacea treatment awareness campaign
Actress and singer Kristin Chenoweth helped kick off a campaign for Rhofade Cream 1% for treating persistent facial erythema associated with rosacea, according to a news release from Allergan.
Chenoweth, who has rosacea, will help raise awareness of rosacea and Rhofade Cream 1% (oxymetazolone chloride), which is available by prescription and indicated for topical treatment of persistent facial erythema associated with rosacea in adults, according to the release.
“Persistent facial redness from rosacea is something I’ve struggled with every day for years,” Chenoweth stated in the release. “Recently, my dermatologist … gave me Rhofade cream, a treatment I use once a day, every day that helps reduce my redness all-day, through 12 hours.
“I’m thrilled to partner with Allergan to raise awareness for the persistent facial redness people with rosacea may dealt with and Rhofade cream. I hope my experience can make a difference for other sufferers who dealt with this challenging condition every day.”
Once-daily application of Rhofade cream was shown to reduce persistent facial erythema associated with rosacea through 12 hours on day 29 in two clinical trials, with results seen in 12% to 18% of people using Rhofade cream compared with 5% to 9% of participants using vehicle cream, according to the release.
Application site dermatitis, worsening inflammatory lesions of rosacea, and pruritus, erythema and pain at the application site were adverse events reported.
Reference: www.allergan.com